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within the past 3months). NineHIV+ participants did not continue
in the study: one elected to be treated at a non-study clinic, two had
psychiatric problems that precluded enrollment, 5 refused to par-
ticipate due to logistics and other reasons, andwewere unable to re-
contact 1. Slightly over half of the HIV-infected participants were
linked to care within 7 days of HIV diagnosis.
Conclusions: Detection of acute and recent HIV infection and
rapid linkage to care is possible. Successful linkage of such
individuals to HIV care including ART can maximize TasP in-
tervention and individual clinical benefits. This approach may be
important for future cure strategies.
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Background: HPTN 065 (TLC-Plus) evaluated the feasibility
and effectiveness of providing quarterly $70 financial incentive
gift cards to HIV-infected patients on antiretroviral therapy who
maintained viral suppression (HIV RNA < 400 copies/mL). A
total of 39,359 FI gift cards were dispensed over 2 years by 19
HIV care sites in the Bronx, NY and Washington, DC.
Methods: Data for each gift card disbursed included dispensing
site, transaction amount, and location of transaction (zip code).
Cards never used and transactions without valid zip codes were
excluded. ZIP Code Tabulation Areas were used to map the
location of transactions by venue (Bronx/DC) and dispensing
site. Python programing and Microsoft Excel 2010 were used for
all analysis and visualization. For transactions that occurred
outside of the local jurisdictions of DC and the Bronx, a random
sample of transactions was examined to identify transactions
made in person versus by internet/phone.
Results: Of 78,529 transactions for gift cards distributed in the
Bronx, 3,611 (4.6%) transactions occurred outside of NY, linked
to 1,852 unique gift cards of the 23,268 distributed. Of 62,022
transactions for gift cards distributed in DC, 3,928 (6.3%) oc-
curred outside of DC, Maryland (MD) and Virginia (VA), linked
to 1,987 unique gift cards of the 16,091 distributed. Transactions
occurred in all 50 US states, Puerto Rico, the Virgin Islands and
international locations. Of gift cards distributed in the Bronx but
used outside of NY state, 62% were used in person and 74% of
the gift cards distributed in DC, but used outside of DC, MD and
VA, were used in person.
Conclusions: Gift cards distributed in this study were primarily
used locally; however, about 5% of transactions were outside the
local jurisdictions and mostly in person. These data suggest that
HIV-infected individuals in the Bronx and DC travel throughout
the US and beyond; thus, research is needed to understand their
migration/travel patterns and the implications for interventions
using ART for prevention.
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Background: The ANRS 12249 TasP cluster-randomised trial
evaluates whether HIV testing of all members of a community,
followed by immediate antiretroviral treatment (ART) for in-
fected people, will prevent onward sexual transmission and re-
duce HIV incidence at population level. Ascertaining the HIV
status of a high proportion of the population regularly and re-
peatedly is key to the success of any universal test and treat
strategy, as the first step of the HIV cascade.
Methods: Between March 2012 and March 2014, we im-
plemented three six-monthly rounds of home-based HIV coun-
selling and testing in ten local communities (clusters). At each
home visit, individual questionnaires were administered and a
rapid HIV test offered to all trial participants. We report early
results on rates of HIV ascertainment, defined as undergoing a
rapid HIV test or HIV-positive self-report.
Results: Of 12,911 eligible individuals (resident in the trial area
and‡ 16 years), 10,007 were successfully contacted at least
once. At first contact, HIV status was ascertained for 7,628
(76.2% [95% CI: 75.4-77.1]) individuals. At second contact,
among the 5,885 individuals contacted a second time, HIV status
was ascertained for 2,829 (85.0% [95% CI: 83.7-86.2]) of the
3,328 tested negative at first contact and for 543 (45.7% [95%
CI: 42.9-48.6]) of the 1,188 who refused a rapid test at first
contact. Overall, HIV ascertainment rate was 89.0% (5,239/
5,885 [95% CI: 88.2-89.8]) among trial participants contacted
twice.
Conclusions: Repeat home-based HIV testing is acceptable and
feasible in this rural area. Socio-demographic characteristics,
behaviours, attitudes, household characteristics and experience
of HIV infection and ART in the household will be explored for
their association with HIV ascertainment uptake. This will in-
form whether this intervention reaches the individuals at higher
risk in a rural South African region.
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